Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors
Clinical trial NCT03511222 · TERMINATED
Trial details
- NCT number
- NCT03511222
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2019-08-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.